The portfolio managers running Hartford Balanced Income are skilled and well-resourced. This income strategy combines two complementary sleeves in a disciplined manner, giving it an edge over its category peers. However, the fees of the more-expensive share classes can overwhelm the combined strengths of the team and approach.
Hartford Balanced Income C HBLCX
- NAV / 1-Day Return 14.45 / +0.63 %
- Total Assets 12.4 Bil
-
Adj. Expense Ratio
- Expense Ratio 1.630%
- Distribution Fee Level Average
- Share Class Type Level Load
- Category Moderately Conservative Allocation
- Investment Style Large Value
- Credit Quality / Interest Rate Sensitivity Medium/Moderate
- Status Open
- TTM Yield 2.77%
- Turnover 57%
USD | NAV as of Jul 26, 2024 | 1-Day Return as of Jul 26, 2024, 10:12 PM GMT+0
Morningstar’s Analysis HBLCX
Will HBLCX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 9.3
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
JPMorgan Chase & Co | 1.56 | 190.5 Mil | Financial Services |
Pfizer Inc | 1.38 | 167.8 Mil | Healthcare |
UnitedHealth Group Inc | 1.27 | 154.4 Mil | Healthcare |
Johnson & Johnson | 1.17 | 142.1 Mil | Healthcare |
Usd | 1.08 | 131.2 Mil | Cash and Equivalents |
2 Year Treasury Note Future Sept 24 | 1.06 | 129.1 Mil | Government |
EOG Resources Inc | 1.01 | 123.4 Mil | Energy |
ConocoPhillips | 0.96 | 116.5 Mil | Energy |
Cisco Systems Inc | 0.95 | 115.7 Mil | Technology |
Merck & Co Inc | 0.92 | 112.5 Mil | Healthcare |